CHMP4C and prostate carcinoma: Previous studies have shown that CHMP4C is abundantly expressed as a component of extracellular vesicles in patients with high Gleason scores and as a novel signature of pyroptosis that affects the prognosis of prostate cancer patients (14) (15).